ToolGen Inc. (199800.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · South Korea
ToolGen Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 890.96 m KRW | 1.31 bn KRW |
| Gross profit | 673.03 m KRW | 1.14 bn KRW |
| Operating income | -21.80 bn KRW | -23.28 bn KRW |
| EBIT | 8.81 bn KRW | -35.68 bn KRW |
| Net income | 6.23 bn KRW | -36.76 bn KRW |
| Diluted EPS – continuing operations | 729.16 KRW | -4,033.21 KRW |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ToolGen Inc.
ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.
More stocks
- Kolon Corp (002020.KS)
- Top Bright Holding Co Ltd (8499.TW)
- Skinkandy Limited (SK1.AX)
- APARTMENT INVESTMENT & MANAGEMENT CO (AIV)
- APPLIED ENERGETICS, INC. (AERG)
- Cica-Huntek Chemical Technology Taiwan Co., Ltd. (6725.TWO)
- Entrada Therapeutics, Inc. (TRDA)
- San Juan Basin Royalty Trust (SJT)
- TTFB Co Ltd (2729.TWO)
- Imperial Petroleum Inc (IMPP)
- TOYO Co., Ltd Ordinary Shares (TOYO)
- Polaris Infrastructure Inc (PIF.TO)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.